One death owing to doxorubicin cardiomyopathy Slightly greater cardiotoxicity (2%) in Q3w group vs Q2w group (1%) [27] Martin et al. BCIRG 001 FAC × 6 vs TAC × 6 1491 55 CHF: 1.6% (DAC ...

Hypertrophic cardiomyopathy (HCM) is a condition that thickens some of the heart’s muscles, making it harder to pump blood. Hypertrophic cardiomyopathy (HCM) usually affects the ventricular ...

Alnylam is riding high today after reporting its RNAi drug vutrisiran showed across-the-board efficacy in cardiomyopathy associated with transthyretin-mediated amyloidosis (ATTR), setting up ...

Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will become the first approved treatment for cardiomyopathy associated with ...